Skip to main content
OpenTrials

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

120 public trials 51 recruiting studies
Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Completed

KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)

NCT01626664

Conditions
Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Miami / Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • National Cancer Institute Bethesda, Maryland, United States
View all 20 locations
View Trial Details
Completed

Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

NCT00217425

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • California Cancer Care, Incorporated - Greenbrae Greenbrae, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Front Range Cancer Specialists Fort Collins, Colorado, United States
  • Rush-Copley Cancer Care Center Aurora, Illinois, United States
View all 110 locations
View Trial Details
Completed

506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL)

NCT00684619

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Robert Bosch Krankenhaus Stuttgart, Baden-Wurttemberg, Germany
  • Klinikum der Universität Regensburg Regensburg, Bavaria, Germany
  • University Hospital of Frankfurt, Medical Dept. II Frankfurt am Main, Hesse, Germany
  • Medizinische Hochschule Hannover Hanover, Lower Saxony, Germany
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

NCT02580552

Conditions
Adult T-Cell Leukemia/Lymphoma (ATLL), Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +29 more
Locations
  • City of Hope Duarte, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Center at University of California, Irvine Orange, California, United States
View all 19 locations
View Trial Details

Related conditions